Onderneming Protagonist Therapeutics Inc Nasdaq
Aandelen
US74366E1029
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- PTS | - |
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Peptide-based Therapeutics
100,0
%
| 27 | 100,0 % | 60 | 100,0 % | +125,73% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 27 | 100,0 % | 60 | 100,0 % | +125,73% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 67 | 01-12-08 |
Asif Ali
DFI | Director of Finance/CFO | 50 | 18-04-22 |
Chief Tech/Sci/R&D Officer | - | 01-07-17 | |
Samuel Saks
CTO | Chief Tech/Sci/R&D Officer | 69 | 24-05-18 |
Arturo Molina
CTO | Chief Tech/Sci/R&D Officer | 65 | 07-11-22 |
Craig Ostroff
LAW | General Counsel | - | - |
Carena Spivey
HRO | Human Resources Officer | - | - |
Suneel Gupta
PRN | Corporate Officer/Principal | 66 | 17-01-19 |
Ashok Bhandari
PRN | Corporate Officer/Principal | - | 01-01-17 |
Carter J. King
PRN | Corporate Officer/Principal | 52 | 01-09-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Lewis Williams
BRD | Director/Board Member | 74 | 08-06-17 |
Harold Selick
CHM | Chairman | 69 | 01-02-09 |
Daniel Swisher
BRD | Director/Board Member | 61 | 26-10-23 |
Dinesh Patel
CEO | Chief Executive Officer | 67 | 01-12-08 |
Sarah O'Dowd
BRD | Director/Board Member | 74 | 12-08-20 |
William Waddill
BRD | Director/Board Member | 67 | 01-07-16 |
Bryan Giraudo
BRD | Director/Board Member | 48 | 16-05-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 58 652 133 | 57 477 242 ( 98,00 %) | 0 | 98,00 % |
Bedrijfsgegevens
Protagonist Therapeutics, Inc.
7707 Gateway Boulevard Suite 140
94560-1160, Newark
+
http://www.protagonist-inc.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+32,80% | 49,46 mld. | |
+1,83% | 42,58 mld. | |
+49,11% | 42,49 mld. | |
-4,22% | 29,09 mld. | |
+11,97% | 26,61 mld. | |
-22,52% | 18,64 mld. | |
+8,31% | 13,16 mld. | |
+31,00% | 12,55 mld. | |
+24,25% | 12,1 mld. |
- Beurs
- Aandelen
- Koers PTGX
- Koers
- Onderneming Protagonist Therapeutics Inc